Sex dimorphism and depot differences in adipose tissue function

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 3, 2014, Pages 377-392

  White, Ursula A ^a   Tchoukalova, Yourka D ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Adipogenesis; Adipokine; Adipose tissue; Fat distribution; Fatty acids; Lipolysis

Indexed keywords

ADIPOCYTOKINE; CHEMERIN; DIPEPTIDYL PEPTIDASE IV; FATTY ACID; GLYPICAN; LEPTIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OMENTIN; SECRETED FRIZZLED RELATED PROTEIN 1; UNCLASSIFIED DRUG; VASPIN;

ADIPOGENESIS; ADIPOSE TISSUE; BODY FAT DISTRIBUTION; DEVELOPMENTAL GENE; FATTY ACID SYNTHESIS; HUMAN; LIPID METABOLISM; LIPID STORAGE; LIPOLYSIS; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; WHITE ADIPOSE TISSUE;

ADIPOGENESIS; ADIPOKINE; ADIPOSE TISSUE; FAT DISTRIBUTION; FATTY ACIDS; LIPOLYSIS;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; BODY COMPOSITION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MICE; OBESITY; SEX CHARACTERISTICS; SUBCUTANEOUS FAT;

EID: 84893704706     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.05.006     Document Type: Review

References (282)

1. Cinti S. The adipose organ at a glance. Dis. Model. Mech. 2012, 5:588-594.
2. Vague J. Not available. La Presse medicale 1947, 55:339.
3. Chan J.M., Rimm E.B., Colditz G.A., Stampfer M.J., Willett W.C. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994, 17:961-969.
4. Carey V.J., Walters E.E., Colditz G.A., Solomon C.G., Willett W.C., Rosner B.A., Speizer F.E., Manson J.E. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study, American journal of epidemiology 1997, 145:614-619.
5. Okosun I.S., Liao Y., Rotimi C.N., Prewitt T.E., Cooper R.S. Abdominal adiposity and clustering of multiple metabolic syndrome in White. Black and Hispanic Americans, Annals of epidemiology 2000, 10:263-270.
6. Seidell J.C., Perusse L., Despres J.P., Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am. J. Clin. Nutr. 2001, 74:315-321.
7. Canoy D., Boekholdt S.M., Wareham N., Luben R., Welch A., Bingham S., Buchan I., Day N., Khaw K.T. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation 2007, 116:2933-2943.
8. Pischon T., Boeing H., Hoffmann K., Bergmann M., Schulze M.B., Overvad K., van der Schouw Y.T., Spencer E., Moons K.G., Tjonneland A., Halkjaer J., Jensen M.K., Stegger J., Clavel-Chapelon F., Boutron-Ruault M.C., Chajes V., Linseisen J., Kaaks R., Trichopoulou A., Trichopoulos D., Bamia C., Sieri S., Palli D., Tumino R., Vineis P., Panico S., Peeters P.H., May A.M., Bueno-de-Mesquita H.B., van Duijnhoven F.J., Hallmans G., Weinehall L., Manjer J., Hedblad B., Lund E., Agudo A., Arriola L., Barricarte A., Navarro C., Martinez C., Quiros J.R., Key T., Bingham S., Khaw K.T., Boffetta P., Jenab M., Ferrari P., Riboli E. General and abdominal adiposity and risk of death in Europe. N. Engl. J. Med. 2008, 359:2105-2120.
9. Kissebah A.H., Vydelingum N., Murray R., Evans D.J., Hartz A.J., Kalkhoff R.K., Adams P.W. Relation of body fat distribution to metabolic complications of obesity. J. Clin. Endocrinol. Metab. 1982, 54:254-260.
10. McLaughlin T., Lamendola C., Liu A., Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J. Clin. Endocrinol. Metab. 2011, 96:E1756-E1760.
11. Kovacova Z., Tencerova M., Roussel B., Wedellova Z., Rossmeislova L., Langin D., Polak J., Stich V. The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue. Int. J. Obes. (Lond) 2011.
12. Amati F., Pennant M., Azuma K., Dube J.J., Toledo F.G., Rossi A.P., Kelley D.E., Goodpaster B.H. Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both contribute to insulin resistance. Obesity 2012, 20:1115-1117.
13. Michaud A., Drolet R., Noel S., Paris G., Tchernof A. Visceral fat accumulation is an indicator of adipose tissue macrophage infiltration in women. Metabolism 2011.
14. Guo Z., Hensrud D.D., Johnson C.M., Jensen M.D. Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 1999, 48:1586-1592.
15. Tordjman J., Divoux A., Prifti E., Poitou C., Pelloux V., Hugol D., Basdevant A., Bouillot J.L., Chevallier J.M., Bedossa P., Guerre-Millo M., Clement K. Structural and inflammatory heterogeneity in subcutaneous adipose tissue: relation with liver histopathology in morbid obesity. J. Hepatol. 2012.
16. Amati F., Pennant M., Azuma K., Dube J.J., Toledo F.G., Rossi A.P., Kelley D.E., Goodpaster B.H. Lower thigh subcutaneous and higher visceral abdominal adipose tissue content both contribute to insulin resistance. Obesity (Silver Spring) 2012.
17. Michaud A., Drolet R., Noel S., Paris G., Tchernof A. Visceral fat accumulation is an indicator of adipose tissue macrophage infiltration in women. Metabolism: clinical and experimental 2012, 61:689-698.
18. Smith S.R., Lovejoy J.C., Greenway F., Ryan D., deJonge L., de la Bretonne J., Volafova J., Bray G.A. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism: clinical and experimental 2001, 50:425-435.
19. Snijder M.B., Dekker J.M., Visser M., Yudkin J.S., Stehouwer C.D., Bouter L.M., Heine R.J., Nijpels G., Seidell J.C. Larger thigh and hip circumferences are associated with better glucose tolerance: the Hoorn study. Obes. Res. 2003, 11:104-111.
20. Snijder M.B., Dekker J.M., Visser M., Bouter L.M., Stehouwer C.D., Yudkin J.S., Heine R.J., Nijpels G., Seidell J.C. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care 2004, 27:372-377.
21. Snijder M.B., Dekker J.M., Visser M., Bouter L.M., Stehouwer C.D., Kostense P.J., Yudkin J.S., Heine R.J., Nijpels G., Seidell J.C. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am. J. Clin. Nutr. 2003, 77:1192-1197.
22. Snijder M.B., Visser M., Dekker J.M., Goodpaster B.H., Harris T.B., Kritchevsky S.B., De Rekeneire N., Kanaya A.M., Newman A.B., Tylavsky F.A., Seidell J.C. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study, Diabetologia 2005, 48:301-308.
23. Pinnick K.E., Neville M.J., Fielding B.A., Frayn K.N., Karpe F., Hodson L. Gluteofemoral adipose tissue plays a major role in production of the lipokine palmitoleate in humans. Diabetes 2012, 61:1399-1403.
24. Manolopoulos K.N., Karpe F., Frayn K.N. Gluteofemoral body fat as a determinant of metabolic health. Int. J. Obes. (Lond) 2010, 34:949-959.
25. Lefterova M.I., Lazar M.A. New developments in adipogenesis. Trends Endocrinol. Metab. 2009, 20:107-114.
26. Seale P., Kajimura S., Spiegelman B.M. Transcriptional control of brown adipocyte development and physiological function - of mice and men. Genes Dev. 2009, 23:788-797.
27. Ravussin E., Galgani J.E. The implication of brown adipose tissue for humans. Annu. Rev. Nutr. 2011, 31:33-47.
28. Gallagher D., Visser M., Sepulveda D., Pierson R.N., Harris T., Heymsfield S.B. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?. Am. J. Epidemiol. 1996, 143:228-239.
29. Jackson A.S., Stanforth P.R., Gagnon J., Rankinen T., Leon A.S., Rao D.C., Skinner J.S., Bouchard C., Wilmore J.H. The effect of sex, age and race on estimating percentage body fat from body mass index: the Heritage Family Study. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity 2002, 26:789-796.
30. Demerath E.W., Sun S.S., Rogers N., Lee M., Reed D., Choh A.C., Couch W., Czerwinski S.A., Chumlea W.C., Siervogel R.M., Towne B. Anatomical patterning of visceral adipose tissue: race, sex, and age variation. Obesity (Silver Spring) 2007, 15:2984-2993.
31. Karastergiou K., Fried S.K. Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ 2012, 3:13.
32. Geer E.B., Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend. Med. 2009, 6(Suppl. 1):60-75.
33. Schreiner P.J., Terry J.G., Evans G.W., Hinson W.H., Crouse J.R., Heiss G. Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices. The Atherosclerosis Risk in Communities Study, Am J Epidemiol 1996, 144:335-345.
34. Despres J.P., Couillard C., Gagnon J., Bergeron J., Leon A.S., Rao D.C., Skinner J.S., Wilmore J.H., Bouchard C. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1932-1938.
35. Camhi S.M., Bray G.A., Bouchard C., Greenway F.L., Johnson W.D., Newton R.L., Ravussin E., Ryan D.H., Smith S.R., Katzmarzyk P.T. The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring) 2011, 19:402-408.
36. Goodpaster B.H., Krishnaswami S., Harris T.B., Katsiaras A., Kritchevsky S.B., Simonsick E.M., Nevitt M., Holvoet P., Newman A.B. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Intern. Med. 2005, 165:777-783.
37. Yim J.E., Heshka S., Albu J.B., Heymsfield S., Gallagher D. Femoral-gluteal subcutaneous and intermuscular adipose tissues have independent and opposing relationships with CVD risk. J. Appl. Physiol. 2008, 104:700-707.
38. Wells J.C. Sexual dimorphism of body composition. Best Pract. Res. Clin. Endocrinol. Metab. 2007, 21:415-430.
39. de Ridder C.M., Bruning P.F., Zonderland M.L., Thijssen J.H., Bonfrer J.M., Blankenstein M.A., Huisveld I.A., Erich W.B. Body fat mass, body fat distribution, and plasma hormones in early puberty in females. J. Clin. Endocrinol. Metab. 1990, 70:888-893.
40. Stevens J., Katz E.G., Huxley R.R. Associations between gender, age and waist circumference. Eur. J. Clin. Nutr. 2010, 64:6-15.
41. Shi H., Clegg D.J. Sex differences in the regulation of body weight. Physiol. Behav. 2009, 97:199-204.
42. Ley C.J., Lees B., Stevenson J.C. Sex- and menopause-associated changes in body-fat distribution. Am. J. Clin. Nutr. 1992, 55:950-954.
43. Svendsen O.L., Hassager C., Christiansen C. Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism: clinical and experimental 1995, 44:369-373.
44. Toth M.J., Tchernof A., Sites C.K., Poehlman E.T. Effect of menopausal status on body composition and abdominal fat distribution. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity 2000, 24:226-231.
45. Piche M.E., Lapointe A., Weisnagel S.J., Corneau L., Nadeau A., Bergeron J., Lemieux S. Regional body fat distribution and metabolic profile in postmenopausal women. Metabolism 2008, 57:1101-1107.
46. Lovejoy J.C., Champagne C.M., de Jonge L., Xie H., Smith S.R. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int. J. Obes. (Lond) 2008, 32:949-958.
47. Kotani K., Tokunaga K., Fujioka S., Kobatake T., Keno Y., Yoshida S., Shimomura I., Tarui S., Matsuzawa Y. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int. J. Obes. Relat. Metab. Disord. 1994, 18. 207-202.
48. Kanaley J.A., Sames C., Swisher L., Swick A.G., Ploutz-Snyder L.L., Steppan C.M., Sagendorf K.S., Feiglin D., Jaynes E.B., Meyer R.A., Weinstock R.S. Abdominal fat distribution in pre- and postmenopausal women: the impact of physical activity, age, and menopausal status. Metabolism 2001, 50:976-982.
49. Perrone G., Liu Y., Capri O., Critelli C., Barillaro F., Galoppi P., Zichella L. Evaluation of the body composition and fat distribution in long-term users of hormone replacement therapy. Gynecol. Obstet. Invest. 1999, 48:52-55.
50. Espeland M.A., Stefanick M.L., Kritz-Silverstein D., Fineberg S.E., Waclawiw M.A., James M.K., Greendale G.A. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators, The Journal of clinical endocrinology and metabolism 1997, 82:1549-1556.
51. Munoz J., Derstine A., Gower B.A. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement. Obes. Res. 2002, 10:424-431.
52. Tchernof A., Poehlman E.T., Despres J.P. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab. 2000, 26:12-20.
53. Derby C.A., Zilber S., Brambilla D., Morales K.H., McKinlay J.B. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin. Endocrinol. 2006, 65:125-131.
54. Puder J.J., Varga S., Kraenzlin M., De Geyter C., Keller U., Muller B. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance. J. Clin. Endocrinol. Metab. 2005, 90:6014-6021.
55. Carmina E., Bucchieri S., Esposito A., Del Puente A., Mansueto P., Orio F., Di Fede G., Rini G. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J. Clin. Endocrinol. Metab. 2007, 92:2500-2505.
56. Escobar-Morreale H.F., San Millan J.L. Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol. Metab. 2007, 18:266-272.
57. Allan C.A., Strauss B.J., Burger H.G., Forbes E.A., McLachlan R.I. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. J. Clin. Endocrinol. Metab. 2008, 93:139-146.
58. Emmelot-Vonk M.H., Verhaar H.J., Nakhai Pour H.R., Aleman A., Lock T.M., Bosch J.L., Grobbee D.E., van der Schouw Y.T. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 2008, 299:39-52.
59. Evans D.J., Hoffmann R.G., Kalkhoff R.K., Kissebah A.H. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J. Clin. Endocrinol. Metab. 1983, 57:304-310.
60. Haffner S.M., Katz M.S., Dunn J.F. Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Int. J. Obes. 1991, 15:471-478.
61. Lovejoy J.C., Bray G.A., Bourgeois M.O., Macchiavelli R., Rood J.C., Greeson C., Partington C. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women - a clinical research center study. J. Clin. Endocrinol. Metab. 1996, 81:2198-2203.
62. Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am. J. Med. 1995, 98:33S-39S.
63. Pedersen S.B., Fuglsig S., Sjogren P., Richelsen B. Identification of steroid receptors in human adipose tissue. Eur. J. Clin. Invest. 1996, 26:1051-1056.
64. Dieudonne M.N., Pecquery R., Boumediene A., Leneveu M.C., Giudicelli Y. Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am. J. Physiol. 1998, 274:C1645-C1652.
65. Anwar A., McTernan P.G., Anderson L.A., Askaa J., Moody C.G., Barnett A.H., Eggo M.C., Kumar S. Site-specific regulation of oestrogen receptor-alpha and -beta by oestradiol in human adipose tissue. Diabetes Obes. Metab. 2001, 3:338-349.
66. Dieudonne M.N., Leneveu M.C., Giudicelli Y., Pecquery R. Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens. Am. J. Physiol. Cell Physiol. 2004, 286:C655-C661.
67. Pedersen S.B., Bruun J.M., Hube F., Kristensen K., Hauner H., Richelsen B. Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Mol. Cell. Endocrinol. 2001, 182:27-37.
68. Gavin K.M., Cooper E.E., Hickner R.C. Estrogen receptor protein content is different in abdominal than gluteal subcutaneous adipose tissue of overweight-to-obese premenopausal women. Metabolism: clinical and experimental 2013.
69. Hall J.M., McDonnell D.P. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999, 140:5566-5578.
70. Jones M.E., Thorburn A.W., Britt K.L., Hewitt K.N., Wreford N.G., Proietto J., Oz O.K., Leury B.J., Robertson K.M., Yao S., Simpson E.R. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:12735-12740.
71. Takeda K., Toda K., Saibara T., Nakagawa M., Saika K., Onishi T., Sugiura T., Shizuta Y. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J. Endocrinol. 2003, 176:237-246.
72. Maffei L., Murata Y., Rochira V., Tubert G., Aranda C., Vazquez M., Clyne C.D., Davis S., Simpson E.R., Carani C. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J. Clin. Endocrinol. Metab. 2004, 89:61-70.
73. Zirilli L., Rochira V., Diazzi C., Caffagni G., Carani C. Human models of aromatase deficiency. J. Steroid Biochem. Mol. Biol. 2008, 109:212-218.
74. Nilsson S., Gustafsson J.A. Estrogen receptors: therapies targeted to receptor subtypes. Clin. Pharmacol. Ther. 2011, 89:44-55.
75. Simpson E.R. Sources of estrogen and their importance. J. Steroid Biochem. Mol. Biol. 2003, 86:225-230.
76. Stocco C. Tissue physiology and pathology of aromatase. Steroids 2012, 77:27-35.
77. Belanger C., Luu-The V., Dupont P., Tchernof A. Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Horm. Metab. Res. 2002, 34:737-745.
78. Meseguer A., Puche C., Cabero A. Sex steroid biosynthesis in white adipose tissue. Horm. Metab. Res. 2002, 34:731-736.
79. Mayes J.S., Watson G.H. Direct effects of sex steroid hormones on adipose tissues and obesity. Obesity reviews: an official journal of the International Association for the Study of Obesity 2004, 5:197-216.
80. Poulos S.P., Hausman D.B., Hausman G.J. The development and endocrine functions of adipose tissue. Mol. Cell. Endocrinol. 2010, 323:20-34.
81. Joe A.W., Yi L., Even Y., Vogl A.W., Rossi F.M. Depot-specific differences in adipogenic progenitor abundance and proliferative response to high-fat diet. Stem Cells 2009, 27:2563-2570.
82. Tchoukalova Y.D., Votruba S.B., Tchkonia T., Giorgadze N., Kirkland J.L., Jensen M.D. Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:18226-18231.
83. Bjorntorp P., Bengtsson C., Blohme G., Jonsson A., Sjostrom L., Tibblin E., Tibblin G., Wilhelmsen L. Adipose tissue fat cell size and number in relation to metabolism in randomly selected middle-aged men and women. Metabolism 1971, 20:927-935.
84. Weyer C., Foley J.E., Bogardus C., Tataranni P.A., Pratley R.E. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000, 43:1498-1506.
85. Lundgren M., Svensson M., Lindmark S., Renstrom F., Ruge T., Eriksson J.W. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia 2007, 50:625-633.
86. Virtue S., Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome - an allostatic perspective. Biochim. Biophys. Acta 2010, 1801:338-349.
87. Isakson P., Hammarstedt A., Gustafson B., Smith U. Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes 2009, 58:1550-1557.
88. Tchoukalova Y., Koutsari C., Jensen M. Committed subcutaneous preadipocytes are reduced in human obesity. Diabetologia 2007, 50:151-157.
89. Hauner H., Ditschuneit H.H., Pal S.B., Moncayo R., Pfeiffer E.F. Fat distribution, endocrine and metabolic profile in obese women with and without hirsutism. Metabolism 1988, 37:281-286.
90. Gregoire F.M., Johnson P.R., Greenwood M.R. Comparison of the adipoconversion of preadipocytes derived from lean and obese Zucker rats in serum-free cultures. Int. J. Obes. Relat. Metab. Disord. 1995, 19:664-670.
91. Tchoukalova Y.D., Koutsari C., Votruba S.B., Tchkonia T., Giorgadze N., Thomou T., Kirkland J.L., Jensen M.D. Sex- and depot-dependent differences in adipogenesis in normal-weight humans. Obesity (Silver Spring) 2010.
92. Spalding K.L., Arner E., Westermark P.O., Bernard S., Buchholz B.A., Bergmann O., Blomqvist L., Hoffstedt J., Naslund E., Britton T., Concha H., Hassan M., Ryden M., Frisen J., Arner P. Dynamics of fat cell turnover in humans. Nature 2008, 453:783-787.
93. Strissel K.J., Stancheva Z., Miyoshi H., Perfield J.W., DeFuria J., Jick Z., Greenberg A.S., Obin M.S. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007, 56:2910-2918.
94. McLaughlin T., Sherman A., Tsao P., Gonzalez O., Yee G., Lamendola C., Reaven G.M., Cushman S.W. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 2007, 50:1707-1715.
95. McLaughlin T.M., Liu T., Yee G., Abbasi F., Lamendola C., Reaven G., Tsao P., Cushman S., Sherman A. Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue. Obesity (Silver Spring) 2009.
96. Lee M.J., Wu Y., Fried S.K. A modified protocol to maximize differentiation of human preadipocytes and improve metabolic phenotypes. Obesity (Silver Spring) 2012, 20:2334-2340.
97. Skurk T., Hauner H. Primary culture of human adipocyte precursor cells: expansion and differentiation. Methods Mol. Biol. 2012, 806:215-226.
98. MacKellar J., Cushman S.W., Periwal V. Waves of adipose tissue growth in the genetically obese Zucker fatty rat. PLoS One 2010, 5:e8197.
99. Arner E., Westermark P.O., Spalding K.L., Britton T., Ryden M., Frisen J., Bernard S., Arner P. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 2010, 59:105-109.
100. Roldan M., Macias-Gonzalez M., Garcia R., Tinahones F.J., Martin M. Obesity short-circuits stemness gene network in human adipose multipotent stem cells. FASEB J. 2011, 25:4111-4126.
101. 2O. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E577-E588.
102. Tchoukalova Y.D., Fitch M., Rogers P.M., Covington J.D., Henagan T.M., Ye J., Hellerstein M.K., Ravussin E. In vivo adipogenesis in rats measured by cell kinetics in adipocytes and plastic-adherent stroma-vascular cells in response to high-fat diet and thiazolidinedione. Diabetes 2012, 61:137-144.
103. 2H-labeling of DNA protocol to measure in vivo cell turnover in adipose tissue. Adipocyte 2012, 1:242-245.
104. Tchkonia T., Lenburg M., Thomou T., Giorgadze N., Frampton G., Pirtskhalava T., Cartwright A., Cartwright M., Flanagan J., Karagiannides I., Gerry N., Forse R.A., Tchoukalova Y., Jensen M.D., Pothoulakis C., Kirkland J.L. Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E298-E307.
105. Van Harmelen V., Rohrig K., Hauner H. Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism 2004, 53:632-637.
106. Hauner H., Entenmann G. Regional variation of adipose differentiation in cultured stromal-vascular cells from the abdominal and femoral adipose tissue of obese women. Int. J. Obes. 1991, 15:121-126.
107. Tchoukalova Y.D., Koutsari C., Votruba S.B., Tchkonia T., Giorgadze N., Thomou T., Kirkland J.L., Jensen M.D. Sex- and depot-dependent differences in adipogenesis in normal-weight humans. Obesity 2010, 18:1875-1880.
108. Maslowska M.H., Sniderman A.D., MacLean L.D., Cianflone K. Regional differences in triacylglycerol synthesis in adipose tissue and in cultured preadipocytes. J. Lipid Res. 1993, 34:219-228.
109. Djian P., Roncari A.K., Hollenberg C.H. Influence of anatomic site and age on the replication and differentiation of rat adipocyte precursors in culture. J. Clin. Invest. 1983, 72:1200-1208.
110. Djian P., Roncari D.A., Hollenberg C.H. Adipocyte precursor clones vary in capacity for differentiation. Metabolism 1985, 34:880-883.
111. Wang H., Kirkland J.L., Hollenberg C.H. Varying capacities for replication of rat adipocyte precursor clones and adipose tissue growth. J. Clin. Invest. 1989, 83:1741-1746.
112. Hauner H., Entenmann G., Wabitsch M., Gaillard D., Ailhaud G., Negrel R., Pfeiffer E.F. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J. Clin. Invest. 1989, 84:1663-1670.
113. Kirkland J.L., Hollenberg C.H., Gillon W.S. Age, anatomic site, and the replication and differentiation of adipocyte precursors. Am. J. Physiol. 1990, 258:C206-C210.
114. Sztalryd C., Faust I.M. Depot-specific features of adipocyte progenitors revealed by primary cultures plated at low density. Int. J. Obes. 1990, 14(Suppl. 3):165-175.
115. Gregoire F., Todoroff G., Hauser N., Remacle C. The stroma-vascular fraction of rat inguinal and epididymal adipose tissue and the adipoconversion of fat cell precursors in primary culture. Biol. Cell 1990, 69:215-222.
116. Kirkland J.L., Hollenberg C.H., Gillon W.S. Two preadipocyte subtypes cloned from human omental fat. Obes. Res. 1993, 1:87-91.
117. Carraro R., Li Z.H., Johnson J.E., Gregerman R.I. Adipocytes of old rats produce a decreased amount of differentiation factor for preadipocytes derived from adipose tissue islets. J. Gerontol. 1992, 47:B198-B201.
118. Kirkland J.L., Hollenberg C.H., Gillon W.S. Effects of fat depot site on differentiation-dependent gene expression in rat preadipocytes. Int. J. Obes. Relat. Metab. Disord. 1996, 20(Suppl. 3):S102-S107.
119. Tchkonia T., Giorgadze N., Pirtskhalava T., Tchoukalova Y., Karagiannides I., Forse R.A., DePonte M., Stevenson M., Guo W., Han J., Waloga G., Lash T.L., Jensen M.D., Kirkland J.L. Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R1286-R1296.
120. Ellis J.R., McDonald R.B., Stern J.S. A diet high in fat stimulates adipocyte proliferation in older (22month) rats. Exp. Gerontol. 1990, 25:141-148.
121. Macotela Y., Emanuelli B., Mori M.A., Gesta S., Schulz T.J., Tseng Y.H., Kahn C.R. Intrinsic differences in adipocyte precursor cells from different white fat depots. Diabetes 2012, 61:1691-1699.
122. Niesler C.U., Siddle K., Prins J.B. Human preadipocytes display a depot-specific susceptibility to apoptosis. Diabetes 1998, 47:1365-1368.
123. Papineau D., Gagnon A., Sorisky A. Apoptosis of human abdominal preadipocytes before and after differentiation into adipocytes in culture. Metabolism 2003, 52:987-992.
124. Maumus M., Sengenes C., Decaunes P., Zakaroff-Girard A., Bourlier V., Lafontan M., Galitzky J., Bouloumie A. Evidence of in situ proliferation of adult adipose tissue-derived progenitor cells: influence of fat mass microenvironment and growth. J. Clin. Endocrinol. Metab. 2008, 93:4098-4106.
125. Maumus M., Peyrafitte J.A., D'Angelo R., Fournier-Wirth C., Bouloumie A., Casteilla L., Sengenes C., Bourin P. Native human adipose stromal cells: localization, morphology and phenotype. Int. J. Obes. (Lond) 2011, 35:1141-1153.
126. Tang W., Zeve D., Seo J., Jo A.Y., Graff J.M. Thiazolidinediones regulate adipose lineage dynamics. Cell Metab. 2011, 14:116-122.
127. Permana P.A., Nair S., Lee Y.H., Luczy-Bachman G., Vozarova De Courten B., Tataranni P.A. Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E958-E962.
128. Baglioni S., Francalanci M., Squecco R., Lombardi A., Cantini G., Angeli R., Gelmini S., Guasti D., Benvenuti S., Annunziato F., Bani D., Liotta F., Francini F., Perigli G., Serio M., Luconi M. Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. FASEB J. 2009, 23:3494-3505.
129. Tchoukalova Y.D., Koutsari C., Karpyak M.V., Votruba S.B., Wendland E., Jensen M.D. Subcutaneous adipocyte size and body fat distribution. Am. J. Clin. Nutr. 2008, 87:56-63.
130. Drolet R., Richard C., Sniderman A.D., Mailloux J., Fortier M., Huot C., Rheaume C., Tchernof A. Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int. J. Obes. (Lond) 2008, 32:283-291.
131. Tchkonia T., Tchoukalova Y.D., Giorgadze N., Pirtskhalava T., Karagiannides I., Forse R.A., Koo A., Stevenson M., Chinnappan D., Cartwright A., Jensen M.D., Kirkland J.L. Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E267-E277.
132. Singh R., Artaza J.N., Taylor W.E., Gonzalez-Cadavid N.F., Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 2003, 144:5081-5088.
133. Singh R., Artaza J.N., Taylor W.E., Braga M., Yuan X., Gonzalez-Cadavid N.F., Bhasin S. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 2006, 147:141-154.
134. Roncari D.A., Van R.L. Promotion of human adipocyte precursor replication by 17beta-estradiol in culture. J. Clin. Invest. 1978, 62:503-508.
135. Lacasa D., Garcia E., Agli B., Giudicelli Y. Control of rat preadipocyte adipose conversion by ovarian status: regional specificity and possible involvement of the mitogen-activated protein kinase-dependent and c-fos signaling pathways. Endocrinology 1997, 138:2729-2734.
136. Anderson L.A., McTernan P.G., Barnett A.H., Kumar S. The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: influence of gender and site. J. Clin. Endocrinol. Metab. 2001, 86:5045-5051.
137. Dieudonne M.N., Pecquery R., Leneveu M.C., Giudicelli Y. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology 2000, 141:649-656.
138. Lacasa D., Le Liepvre X., Ferre P., Dugail I. Progesterone stimulates adipocyte determination and differentiation 1/sterol regulatory element-binding protein 1c gene expression. potential mechanism for the lipogenic effect of progesterone in adipose tissue. J. Biol. Chem. 2001, 276:11512-11516.
139. Bulun S.E., Simpson E.R. Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. J. Clin. Endocrinol. Metab. 1994, 78:428-432.
140. Yang X., Schadt E.E., Wang S., Wang H., Arnold A.P., Ingram-Drake L., Drake T.A., Lusis A.J. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 2006, 16:995-1004.
141. Gustafson B., Gogg S., Hedjazifar S., Jenndahl L., Hammarstedt A., Smith U. Inflammation and impaired adipogenesis in hypertrophic obesity in man. Am. J. Physiol. Endocrinol. Metab. 2009.
142. Cantile M., Procino A., D'Armiento M., Cindolo L., Cillo C. HOX gene network is involved in the transcriptional regulation of in vivo human adipogenesis. J. Cell. Physiol. 2003, 194:225-236.
143. Vohl M.C., Sladek R., Robitaille J., Gurd S., Marceau P., Richard D., Hudson T.J., Tchernof A. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes. Res. 2004, 12:1217-1222.
144. Gesta S., Bluher M., Yamamoto Y., Norris A.W., Berndt J., Kralisch S., Boucher J., Lewis C., Kahn C.R. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc. Natl. Acad. Sci. USA 2006, 103:6676-6681.
145. Tchkonia T., Giorgadze N., Pirtskhalava T., Thomou T., DePonte M., Koo A., Forse R.A., Chinnappan D., Martin-Ruiz C., von Zglinicki T., Kirkland J.L. Fat depot-specific characteristics are retained in strains derived from single human preadipocytes. Diabetes 2006, 55:2571-2578.
146. Karastergiou K., Fried S.K., Xie H., Lee M.J., Divoux A., Rosencrantz M.A., Chang R.J., Smith S.R. Distinct developmental signatures of human abdominal and gluteal subcutaneous adipose tissue depots. J. Clin. Endocrinol. Metab. 2012.
147. Heid I.M., Jackson A.U., Randall J.C., Winkler T.W., Qi L., Steinthorsdottir V., Thorleifsson G., Zillikens M.C., Speliotes E.K., Magi R., Workalemahu T., White C.C., Bouatia-Naji N., Harris T.B., Berndt S.I., Ingelsson E., Willer C.J., Weedon M.N., Luan J., Vedantam S., Esko T., Kilpelainen T.O., Kutalik Z., Li S., Monda K.L., Dixon A.L., Holmes C.C., Kaplan L.M., Liang L., Min J.L., Moffatt M.F., Molony C., Nicholson G., Schadt E.E., Zondervan K.T., Feitosa M.F., Ferreira T., Lango Allen H., Weyant R.J., Wheeler E., Wood A.R., Estrada K., Goddard M.E., Lettre G., Mangino M., Nyholt D.R., Purcell S., Smith A.V., Visscher P.M., Yang J., McCarroll S.A., Nemesh J., Voight B.F., Absher D., Amin N., Aspelund T., Coin L., Glazer N.L., Hayward C., Heard-Costa N.L., Hottenga J.J., Johansson A., Johnson T., Kaakinen M., Kapur K., Ketkar S., Knowles J.W., Kraft P., Kraja A.T., Lamina C., Leitzmann M.F., McKnight B., Morris A.P., Ong K.K., Perry J.R., Peters M.J., Polasek O., Prokopenko I., Rayner N.W., Ripatti S., Rivadeneira F., Robertson N.R., Sanna S., Sovio U., Surakka I., Teumer A., van Wingerden S., Vitart V., Zhao J.H., Cavalcanti-Proenca C., Chines P.S., Fisher E., Kulzer J.R., Lecoeur C., Narisu N., Sandholt C., Scott L.J., Silander K., Stark K., Tammesoo M.L., Teslovich T.M., Timpson N.J., Watanabe R.M., Welch R., Chasman D.I., Cooper M.N., Jansson J.O., Kettunen J., Lawrence R.W., Pellikka N., Perola M., Vandenput L., Alavere H., Almgren P., Atwood L.D., Bennett A.J., Biffar R., Bonnycastle L.L., Bornstein S.R., Buchanan T.A., Campbell H., Day I.N., Dei M., Dorr M., Elliott P., Erdos M.R., Eriksson J.G., Freimer N.B., Fu M., Gaget S., Geus E.J., Gjesing A.P., Grallert H., Grassler J., Groves C.J., Guiducci C., Hartikainen A.L., Hassanali N., Havulinna A.S., Herzig K.H., Hicks A.A., Hui J., Igl W., Jousilahti P., Jula A., Kajantie E., Kinnunen L., Kolcic I., Koskinen S., Kovacs P., Kroemer H.K., Krzelj V., Kuusisto J., Kvaloy K., Laitinen J., Lantieri O., Lathrop G.M., Lokki M.L., Luben R.N., Ludwig B., McArdle W.L., McCarthy A., Morken M.A., Nelis M., Neville M.J., Pare G., Parker A.N., Peden J.F., Pichler I., Pietilainen K.H., Platou C.G., Pouta A., Ridderstrale M., Samani N.J., Saramies J., Sinisalo J., Smit J.H., Strawbridge R.J., Stringham H.M., Swift A.J., Teder-Laving M., Thomson B., Usala G., van Meurs J.B., van Ommen G.J., Vatin V., Volpato C.B., Wallaschofski H., Walters G.B., Widen E., Wild S.H., Willemsen G., Witte D.R., Zgaga L., Zitting P., Beilby J.P., James A.L., Kahonen M., Lehtimaki T., Nieminen M.S., Ohlsson C., Palmer L.J., Raitakari O., Ridker P.M., Stumvoll M., Tonjes A., Viikari J., Balkau B., Ben-Shlomo Y., Bergman R.N., Boeing H., Smith G.D., Ebrahim S., Froguel P., Hansen T., Hengstenberg C., Hveem K., Isomaa B., Jorgensen T., Karpe F., Khaw K.T., Laakso M., Lawlor D.A., Marre M., Meitinger T., Metspalu A., Midthjell K., Pedersen O., Salomaa V., Schwarz P.E., Tuomi T., Tuomilehto J., Valle T.T., Wareham N.J., Arnold A.M., Beckmann J.S., Bergmann S., Boerwinkle E., Boomsma D.I., Caulfield M.J., Collins F.S., Eiriksdottir G., Gudnason V., Gyllensten U., Hamsten A., Hattersley A.T., Hofman A., Hu F.B., Illig T., Iribarren C., Jarvelin M.R., Kao W.H., Kaprio J., Launer L.J., Munroe P.B., Oostra B., Penninx B.W., Pramstaller P.P., Psaty B.M., Quertermous T., Rissanen A., Rudan I., Shuldiner A.R., Soranzo N., Spector T.D., Syvanen A.C., Uda M., Uitterlinden A., Volzke H., Vollenweider P., Wilson J.F., Witteman J.C., Wright A.F., Abecasis G.R., Boehnke M., Borecki I.B., Deloukas P., Frayling T.M., Groop L.C., Haritunians T., Hunter D.J., Kaplan R.C., North K.E., O'Connell J.R., Peltonen L., Schlessinger D., Strachan D.P., Hirschhorn J.N., Assimes T.L., Wichmann H.E., Thorsteinsdottir U., van Duijn C.M., Stefansson K., Cupples L.A., Loos R.J., Barroso I., McCarthy M.I., Fox C.S., Mohlke K.L., Lindgren C.M. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 2010, 42:949-960.
148. Holland P.W., Booth H.A., Bruford E.A. Classification and nomenclature of all human homeobox genes. BMC Biol. 2007, 5:47.
149. Hombria J.C., Lovegrove B. Beyond homeosis - HOX function in morphogenesis and organogenesis. Differentiation; research in biological diversity 2003, 71:461-476.
150. Cartwright M.J., Schlauch K., Lenburg M.E., Tchkonia T., Pirtskhalava T., Cartwright A., Thomou T., Kirkland J.L. Aging, depot origin, and preadipocyte gene expression. J. Gerontol. A Biol. Sci. Med. Sci. 2010, 65:242-251.
151. Yamamoto Y., Gesta S., Lee K.Y., Tran T.T., Saadatirad P., Kahn C.R. Adipose depots possess unique developmental gene signatures. Obesity (Silver Spring) 2010, 18:872-878.
152. Monteiro M.C., Sanyal M., Cleary M.L., Sengenes C., Bouloumie A., Dani C., Billon N. PBX1: a novel stage-specific regulator of adipocyte development. Stem Cells 2011, 29:1837-1848.
153. Heid I.M., Jackson A.U., Randall J.C., Winkler T.W., Qi L., Steinthorsdottir V., Thorleifsson G., Zillikens M.C., Speliotes E.K., Magi R., Workalemahu T., White C.C., Bouatia-Naji N., Harris T.B., Berndt S.I., Ingelsson E., Willer C.J., Weedon M.N., Luan J., Vedantam S., Esko T., Kilpelainen T.O., Kutalik Z., Li S., Monda K.L., Dixon A.L., Holmes C.C., Kaplan L.M., Liang L., Min J.L., Moffatt M.F., Molony C., Nicholson G., Schadt E.E., Zondervan K.T., Feitosa M.F., Ferreira T., Allen H.L., Weyant R.J., Wheeler E., Wood A.R., Magic K.Estrada, Goddard M.E., Lettre G., Mangino M., Nyholt D.R., Purcell S., Smith A.V., Visscher P.M., Yang J., McCarroll S.A., Nemesh J., Voight B.F., Absher D., Amin N., Aspelund T., Coin L., Glazer N.L., Hayward C., Heard-Costa N.L., Hottenga J.J., Johansson A., Johnson T., Kaakinen M., Kapur K., Ketkar S., Knowles J.W., Kraft P., Kraja A.T., Lamina C., Leitzmann M.F., McKnight B., Morris A.P., Ong K.K., Perry J.R., Peters M.J., Polasek O., Prokopenko I., Rayner N.W., Ripatti S., Rivadeneira F., Robertson N.R., Sanna S., Sovio U., Surakka I., Teumer A., van Wingerden S., Vitart V., Zhao J.H., Cavalcanti-Proenca C., Chines P.S., Fisher E., Kulzer J.R., Lecoeur C., Narisu N., Sandholt C., Scott L.J., Silander K., Stark K., Tammesoo M.L., Teslovich T.M., Timpson N.J., Watanabe R.M., Welch R., Chasman D.I., Cooper M.N., Jansson J.O., Kettunen J., Lawrence R.W., Pellikka N., Perola M., Vandenput L., Alavere H., Almgren P., Atwood L.D., Bennett A.J., Biffar R., Bonnycastle L.L., Bornstein S.R., Buchanan T.A., Campbell H., Day I.N., Dei M., Dorr M., Elliott P., Erdos M.R., Eriksson J.G., Freimer N.B., Fu M., Gaget S., Geus E.J., Gjesing A.P., Grallert H., Grassler J., Groves C.J., Guiducci C., Hartikainen A.L., Hassanali N., Havulinna A.S., Herzig K.H., Hicks A.A., Hui J., Igl W., Jousilahti P., Jula A., Kajantie E., Kinnunen L., Kolcic I., Koskinen S., Kovacs P., Kroemer H.K., Krzelj V., Kuusisto J., Kvaloy K., Laitinen J., Lantieri O., Lathrop G.M., Lokki M.L., Luben R.N., Ludwig B., McArdle W.L., McCarthy A., Morken M.A., Nelis M., Neville M.J., Pare G., Parker A.N., Peden J.F., Pichler I., Pietilainen K.H., Platou C.G., Pouta A., Ridderstrale M., Samani N.J., Saramies J., Sinisalo J., Smit J.H., Strawbridge R.J., Stringham H.M., Swift A.J., Teder-Laving M., Thomson B., Usala G., van Meurs J.B., van Ommen G.J., Vatin V., Volpato C.B., Wallaschofski H., Walters G.B., Widen E., Wild S.H., Willemsen G., Witte D.R., Zgaga L., Zitting P., Beilby J.P., James A.L., Kahonen M., Lehtimaki T., Nieminen M.S., Ohlsson C., Palmer L.J., Raitakari O., Ridker P.M., Stumvoll M., Tonjes A., Viikari J., Balkau B., Ben-Shlomo Y., Bergman R.N., Boeing H., Smith G.D., Ebrahim S., Froguel P., Hansen T., Hengstenberg C., Hveem K., Isomaa B., Jorgensen T., Karpe F., Khaw K.T., Laakso M., Lawlor D.A., Marre M., Meitinger T., Metspalu A., Midthjell K., Pedersen O., Salomaa V., Schwarz P.E., Tuomi T., Tuomilehto J., Valle T.T., Wareham N.J., Arnold A.M., Beckmann J.S., Bergmann S., Boerwinkle E., Boomsma D.I., Caulfield M.J., Collins F.S., Eiriksdottir G., Gudnason V., Gyllensten U., Hamsten A., Hattersley A.T., Hofman A., Hu F.B., Illig T., Iribarren C., Jarvelin M.R., Kao W.H., Kaprio J., Launer L.J., Munroe P.B., Oostra B., Penninx B.W., Pramstaller P.P., Psaty B.M., Quertermous T., Rissanen A., Rudan I., Shuldiner A.R., Soranzo N., Spector T.D., Syvanen A.C., Uda M., Uitterlinden A., Volzke H., Vollenweider P., Wilson J.F., Witteman J.C., Wright A.F., Abecasis G.R., Boehnke M., Borecki I.B., Deloukas P., Frayling T.M., Groop L.C., Haritunians T., Hunter D.J., Kaplan R.C., North K.E., O'Connell J.R., Peltonen L., Schlessinger D., Strachan D.P., Hirschhorn J.N., Assimes T.L., Wichmann H.E., Thorsteinsdottir U., van Duijn C.M., Stefansson K., Cupples L.A., Loos R.J., Barroso I., McCarthy M.I., Fox C.S., Mohlke K.L., Lindgren C.M. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 2010, 42:949-960.
154. Lindgren C.M., Heid I.M., Randall J.C., Lamina C., Steinthorsdottir V., Qi L., Speliotes E.K., Thorleifsson G., Willer C.J., Herrera B.M., Jackson A.U., Lim N., Scheet P., Soranzo N., Amin N., Aulchenko Y.S., Chambers J.C., Drong A., Luan J., Lyon H.N., Rivadeneira F., Sanna S., Timpson N.J., Zillikens M.C., Zhao J.H., Almgren P., Bandinelli S., Bennett A.J., Bergman R.N., Bonnycastle L.L., Bumpstead S.J., Chanock S.J., Cherkas L., Chines P., Coin L., Cooper C., Crawford G., Doering A., Dominiczak A., Doney A.S., Ebrahim S., Elliott P., Erdos M.R., Estrada K., Ferrucci L., Fischer G., Forouhi N.G., Gieger C., Grallert H., Groves C.J., Grundy S., Guiducci C., Hadley D., Hamsten A., Havulinna A.S., Hofman A., Holle R., Holloway J.W., Illig T., Isomaa B., Jacobs L.C., Jameson K., Jousilahti P., Karpe F., Kuusisto J., Laitinen J., Lathrop G.M., Lawlor D.A., Mangino M., McArdle W.L., Meitinger T., Morken M.A., Morris A.P., Munroe P., Narisu N., Nordstrom A., Nordstrom P., Oostra B.A., Palmer C.N., Payne F., Peden J.F., Prokopenko I., Renstrom F., Ruokonen A., Salomaa V., Sandhu M.S., Scott L.J., Scuteri A., Silander K., Song K., Yuan X., Stringham H.M., Swift A.J., Tuomi T., Uda M., Vollenweider P., Waeber G., Wallace C., Walters G.B., Weedon M.N., Wellcome Trust Case Control C., Witteman J.C., Zhang C., Zhang W., Caulfield M.J., Collins F.S., Davey Smith G., Day I.N., Franks P.W., Hattersley A.T., Hu F.B., Jarvelin M.R., Kong A., Kooner J.S., Laakso M., Lakatta E., Mooser V., Morris A.D., Peltonen L., Samani N.J., Spector T.D., Strachan D.P., Tanaka T., Tuomilehto J., Uitterlinden A.G., van Duijn C.M., Wareham N.J., Hugh W., Procardis C., Waterworth D.M., Boehnke M., Deloukas P., Groop L., Hunter D.J., Thorsteinsdottir U., Schlessinger D., Wichmann H.E., Frayling T.M., Abecasis G.R., Hirschhorn J.N., Loos R.J., Stefansson K., Mohlke K.L., Barroso I., McCarthy M.I., Giant C. Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet. 2009, 5:e1000508.
155. Nilsson C., Niklasson M., Eriksson E., Bjorntorp P., Holmang A. Imprinting of female offspring with testosterone results in insulin resistance and changes in body fat distribution at adult age in rats. J. Clin. Invest. 1998, 101:74-78.
156. Okura T., Koda M., Ando F., Niino N., Ohta S., Shimokata H. Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity 2003, 27:1020-1027.
157. Gallagher C.J., Langefeld C.D., Gordon C.J., Campbell J.K., Mychaleckyj J.C., Bryer-Ash M., Rich S.S., Bowden D.W., Sale M.M. Association of the estrogen receptor-alpha gene with the metabolic syndrome and its component traits in African-American families: the Insulin Resistance Atherosclerosis Family Study. Diabetes 2007, 56:2135-2141.
158. Daftary G.S., Taylor H.S. Endocrine regulation of HOX genes. Endocr. Rev. 2006, 27:331-355.
159. Karastergiou K., Fried S.K., Xie H., Lee M.J., Divoux A., Rosencrantz M.A., Chang R.J., Smith S.R. Distinct developmental signatures of human abdominal and gluteal subcutaneous adipose tissue depots. J. Clin. Endocrinol. Metab. 2013, 98:362-371.
160. Bluher M. Are there still healthy obese patients?. Curr. Opin. Endocrinol. Diabetes Obes. 2012, 19:341-346.
161. Hube F., Lietz U., Igel M., Jensen P.B., Tornqvist H., Joost H.G., Hauner H. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm. Metab. Res. 1996, 28:690-693.
162. Montague C.T., Prins J.B., Sanders L., Zhang J., Sewter C.P., Digby J., Byrne C.D., O'Rahilly S. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 1998, 47:1384-1391.
163. Nielsen N.B., Hojbjerre L., Sonne M.P., Alibegovic A.C., Vaag A., Dela F., Stallknecht B. Interstitial concentrations of adipokines in subcutaneous abdominal and femoral adipose tissue. Regul. Pept. 2009, 155:39-45.
164. Snijder M.B., Flyvbjerg A., Stehouwer C.D., Frystyk J., Henry R.M., Seidell J.C., Heine R.J., Dekker J.M. Relationship of adiposity with arterial stiffness as mediated by adiponectin in older men and women: the Hoorn Study. Eur. J. Endocrinol. 2009, 160:387-395.
165. Fisher F.M., McTernan P.G., Valsamakis G., Chetty R., Harte A.L., Anwar A.J., Starcynski J., Crocker J., Barnett A.H., McTernan C.L., Kumar S. Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status. Horm. Metab. Res. 2002, 34:650-654.
166. Ryo M., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi M., Nagai M., Matsuzawa Y., Funahashi T. Adiponectin as a biomarker of the metabolic syndrome. Circ. J. 2004, 68:975-981.
167. Vettor R., De Pergola G., Pagano C., Englaro P., Laudadio E., Giorgino F., Blum W.F., Giorgino R., Federspil G. Gender differences in serum leptin in obese people: relationships with testosterone, body fat distribution and insulin sensitivity. Eur. J. Clin. Invest. 1997, 27:1016-1024.
168. Saad M.F., Damani S., Gingerich R.L., Riad-Gabriel M.G., Khan A., Boyadjian R., Jinagouda S.D., el-Tawil K., Rude R.K., Kamdar V. Sexual dimorphism in plasma leptin concentration. J. Clin. Endocrinol. Metab. 1997, 82:579-584.
169. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257:79-83.
170. Nishizawa H., Shimomura I., Kishida K., Maeda N., Kuriyama H., Nagaretani H., Matsuda M., Kondo H., Furuyama N., Kihara S., Nakamura T., Tochino Y., Funahashi T., Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002, 51:2734-2741.
171. Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., Retzlaff B.M., Knopp R.H., Brunzell J.D., Kahn S.E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46:459-469.
172. Kloting N., Wilke B., Kloting I. Alleles on rat chromosome 4 (D4Got41-Fabp1/Tacr1) regulate subphenotypes of obesity. Obes. Res. 2005, 13:589-595.
173. Gavi S., Qurashi S., Stuart L.M., Lau R., Melendez M.M., Mynarcik D.C., McNurlan M.A., Gelato M.C. Influence of age on the association of retinol-binding protein 4 with metabolic syndrome. Obesity (Silver Spring) 2008, 16:893-895.
174. Shimomura I., Funahashi T., Takahashi M., Maeda K., Kotani K., Nakamura T., Yamashita S., Miura M., Fukuda Y., Takemura K., Tokunaga K., Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat. Med. 1996, 2:800-803.
175. Lamers D., Famulla S., Wronkowitz N., Hartwig S., Lehr S., Ouwens D.M., Eckardt K., Kaufman J.M., Ryden M., Muller S., Hanisch F.G., Ruige J., Arner P., Sell H., Eckel J. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 2011, 60:1917-1925.
176. Roh S.G., Song S.H., Choi K.C., Katoh K., Wittamer V., Parmentier M., Sasaki S. Chemerin - a new adipokine that modulates adipogenesis via its own receptor. Biochem. Biophys. Res. Commun. 2007, 362:1013-1018.
177. Parolini S., Santoro A., Marcenaro E., Luini W., Massardi L., Facchetti F., Communi D., Parmentier M., Majorana A., Sironi M., Tabellini G., Moretta A., Sozzani S. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007, 109:3625-3632.
178. Barnea G., Strapps W., Herrada G., Berman Y., Ong J., Kloss B., Axel R., Lee K.J. The genetic design of signaling cascades to record receptor activation. Proc. Natl. Acad. Sci. USA 2008, 105:64-69.
179. Zabel B.A., Nakae S., Zuniga L., Kim J.Y., Ohyama T., Alt C., Pan J., Suto H., Soler D., Allen S.J., Handel T.M., Song C.H., Galli S.J., Butcher E.C. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J. Exp. Med. 2008, 205:2207-2220.
180. Monnier J., Lewen S., O'Hara E., Huang K., Tu H., Butcher E.C., Zabel B.A. Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells. J. Immunol. 2012, 189:956-967.
181. Ernst M.C., Haidl I.D., Zuniga L.A., Dranse H.J., Rourke J.L., Zabel B.A., Butcher E.C., Sinal C.J. Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology 2012, 153:672-682.
182. Goralski K.B., McCarthy T.C., Hanniman E.A., Zabel B.A., Butcher E.C., Parlee S.D., Muruganandan S., Sinal C.J. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J. Biol. Chem. 2007, 282:28175-28188.
183. Albanesi C., Scarponi C., Pallotta S., Daniele R., Bosisio D., Madonna S., Fortugno P., Gonzalvo-Feo S., Franssen J.D., Parmentier M., De Pita O., Girolomoni G., Sozzani S. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med. 2009, 206:249-258.
184. Bauer S., Wanninger J., Schmidhofer S., Weigert J., Neumeier M., Dorn C., Hellerbrand C., Zimara N., Schaffler A., Aslanidis C., Buechler C. Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. Endocrinology 2011, 152:26-35.
185. Kralisch S., Weise S., Sommer G., Lipfert J., Lossner U., Bluher M., Stumvoll M., Fasshauer M. Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro. Regul. Pept. 2009, 154:102-106.
186. Hart R., Greaves D.R. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J. Immunol. 2010, 185:3728-3739.
187. Cash J.L., Hart R., Russ A., Dixon J.P., Colledge W.H., Doran J., Hendrick A.G., Carlton M.B., Greaves D.R. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med. 2008, 205:767-775.
188. Jialal I., Devaraj S., Kaur H., Adams-Huet B., Bremer A.A. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J. Clin. Endocrinol. Metab. 2013.
189. Shin H.Y., Lee D.C., Chu S.H., Jeon J.Y., Lee M.K., Im J.A., Lee J.W. Chemerin levels are positively correlated with abdominal visceral fat accumulation. Clin. Endocrinol. 2012, 77:47-50.
190. Luque-Ramirez M., Martinez-Garcia M.A., Montes-Nieto R., Fernandez-Duran E., Insenser M., Alpanes M., Escobar-Morreale H.F. Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge. Hum. Reprod. 2013.
191. Martinez-Garcia M.A., Montes-Nieto R., Fernandez-Duran E., Insenser M., Luque-Ramirez M., Escobar-Morreale H.F. Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS). J. Clin. Endocrinol. Metab. 2013, 98:E388-E396.
192. Alfadda A.A., Sallam R.M., Chishti M.A., Moustafa A.S., Fatma S., Alomaim W.S., Al-Naami M.Y., Bassas A.F., Chrousos G.P., Jo H. Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism. Mol. Cells 2012, 33:591-596.
193. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11:85-97.
194. Moreno-Navarrete J.M., Manco M., Ibanez J., Garcia-Fuentes E., Ortega F., Gorostiaga E., Vendrell J., Izquierdo M., Martinez C., Nolfe G., Ricart W., Mingrone G., Tinahones F., Fernandez-Real J.M. Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. Int. J. Obes. (Lond) 2010, 34:240-249.
195. Diamanti-Kandarakis E., Livadas S., Kandarakis S.A., Margeli A., Papassotiriou I. Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?. European journal of endocrinology/European Federation of Endocrine Societies 2008, 158:525-531.
196. Koiou E., Tziomalos K., Katsikis I., Kandaraki E.A., Kalaitzakis E., Delkos D., Vosnakis C., Panidis D. Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology 2012, 28:20-24.
197. Cakal E., Ozkaya M., Engin-Ustun Y., Ustun Y. Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome. J. Endocrinol. Invest. 2011, 34:97-100.
198. Law I.K., Xu A., Lam K.S., Berger T., Mak T.W., Vanhoutte P.M., Liu J.T., Sweeney G., Zhou M., Yang B., Wang Y. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes 2010, 59:872-882.
199. Guo H., Jin D., Zhang Y., Wright W., Bazuine M., Brockman D.A., Bernlohr D.A., Chen X. Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes 2010, 59:1376-1385.
200. Yan Q.W., Yang Q., Mody N., Graham T.E., Hsu C.H., Xu Z., Houstis N.E., Kahn B.B., Rosen E.D. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 2007, 56:2533-2540.
201. Zhang J., Wu Y., Zhang Y., Leroith D., Bernlohr D.A., Chen X. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol. Endocrinol. 2008, 22:1416-1426.
202. Cowland J.B., Muta T., Borregaard N. IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. J. Immunol. 2006, 176:5559-5566.
203. Wang Y., Lam K.S., Kraegen E.W., Sweeney G., Zhang J., Tso A.W., Chow W.S., Wat N.M., Xu J.Y., Hoo R.L., Xu A. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin. Chem. 2007, 53:34-41.
204. Catalan V., Gomez-Ambrosi J., Rodriguez A., Ramirez B., Silva C., Rotellar F., Gil M.J., Cienfuegos J.A., Salvador J., Fruhbeck G. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans. J Mol Med (Berl) 2009, 87:803-813.
205. Ussar S., Bezy O., Bluher M., Kahn C.R. Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine. Diabetes 2012, 61:2289-2298.
206. Yang R.Z., Lee M.J., Hu H., Pray J., Wu H.B., Hansen B.C., Shuldiner A.R., Fried S.K., McLenithan J.C., Gong D.W. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E1253-E1261.
207. de Souza Batista C.M., Yang R.Z., Lee M.J., Glynn N.M., Yu D.Z., Pray J., Ndubuizu K., Patil S., Schwartz A., Kligman M., Fried S.K., Gong D.W., Shuldiner A.R., Pollin T.I., McLenithan J.C. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007, 56:1655-1661.
208. Shibata R., Ouchi N., Takahashi R., Terakura Y., Ohashi K., Ikeda N., Higuchi A., Terasaki H., Kihara S., Murohara T. Omentin as a novel biomarker of metabolic risk factors. Diabetology & metabolic syndrome 2012, 4:37.
209. Tan B.K., Adya R., Randeva H.S. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc. Med. 2010, 20:143-148.
210. Barth S., Klein P., Horbach T., Dotsch J., Rauh M., Rascher W., Knerr I. Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: relation to endocrine and clinical parameters. Obes. Facts 2010, 3:245-251.
211. Zhong X., Li X., Liu F., Tan H., Shang D. Omentin inhibits TNF-alpha-induced expression of adhesion molecules in endothelial cells via ERK/NF-kappaB pathway. Biochem. Biophys. Res. Commun. 2012, 425:401-406.
212. Kazama K., Usui T., Okada M., Hara Y., Yamawaki H. Omentin plays an anti-inflammatory role through inhibition of TNF-alpha-induced superoxide production in vascular smooth muscle cells. Eur. J. Pharmacol. 2012, 686:116-123.
213. Kawano Y., Kypta R. Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 2003, 116:2627-2634.
214. Christodoulides C., Lagathu C., Sethi J.K., Vidal-Puig A. Adipogenesis and WNT signalling. Trends Endocrinol. Metab. 2009, 20:16-24.
215. Lagathu C., Christodoulides C., Tan C.Y., Virtue S., Laudes M., Campbell M., Ishikawa K., Ortega F., Tinahones F.J., Fernandez-Real J.M., Oresic M., Sethi J.K., Vidal-Puig A. Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity. Int. J. Obes. (Lond) 2010, 34:1695-1705.
216. Park J.R., Jung J.W., Lee Y.S., Kang K.S. The roles of Wnt antagonists Dkk1 and sFRP4 during adipogenesis of human adipose tissue-derived mesenchymal stem cells. Cell Prolif. 2008, 41:859-874.
217. Ehrlund A., Mejhert N., Lorente-Cebrian S., Astrom G., Dahlman I., Laurencikiene J., Ryden M. Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue. J. Clin. Endocrinol. Metab. 2013.
218. Ouchi N., Higuchi A., Ohashi K., Oshima Y., Gokce N., Shibata R., Akasaki Y., Shimono A., Walsh K. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 2010, 329:454-457.
219. Hu W., Li L., Yang M., Luo X., Ran W., Liu D., Xiong Z., Liu H., Yang G. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. J. Clin. Endocrinol. Metab. 2013, 98:290-298.
220. Koza R.A., Nikonova L., Hogan J., Rim J.S., Mendoza T., Faulk C., Skaf J., Kozak L.P. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet. 2006, 2:e81.
221. Okada Y., Sakaue H., Nagare T., Kasuga M. Diet-induced up-regulation of gene expression in adipocytes without changes in DNA methylation. Kobe J. Med. Sci. 2009, 54:E241-E249.
222. Kloting N., Berndt J., Kralisch S., Kovacs P., Fasshauer M., Schon M.R., Stumvoll M., Bluher M. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem. Biophys. Res. Commun. 2006, 339:430-436.
223. Hida K., Wada J., Eguchi J., Zhang H., Baba M., Seida A., Hashimoto I., Okada T., Yasuhara A., Nakatsuka A., Shikata K., Hourai S., Futami J., Watanabe E., Matsuki Y., Hiramatsu R., Akagi S., Makino H., Kanwar Y.S. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10610-10615.
224. Youn B.S., Kloting N., Kratzsch J., Lee N., Park J.W., Song E.S., Ruschke K., Oberbach A., Fasshauer M., Stumvoll M., Bluher M. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008, 57:372-377.
225. Seeger J., Ziegelmeier M., Bachmann A., Lossner U., Kratzsch J., Bluher M., Stumvoll M., Fasshauer M. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J. Clin. Endocrinol. Metab. 2008, 93:247-251.
226. Piya M.K., McTernan P.G., Kumar S. Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin. J. Endocrinol. 2013, 216:T1-T15.
227. Nielsen S., Guo Z., Albu J.B., Klein S., O'Brien P.C., Jensen M.D. Energy expenditure, sex, and endogenous fuel availability in humans. J. Clin. Invest. 2003, 111:981-988.
228. Koutsari C., Basu R., Rizza R.A., Nair K.S., Khosla S., Jensen M.D. Nonoxidative free fatty acid disposal is greater in young women than men. J. Clin. Endocrinol. Metab. 2011, 96:541-547.
229. Karpe F., Dickmann J.R., Frayn K.N. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 2011, 60:2441-2449.
230. Wahrenberg H., Lonnqvist F., Arner P. Mechanisms underlying regional differences in lipolysis in human adipose tissue. J. Clin. Invest. 1989, 84:458-467.
231. Fried S.K., Leibel R.L., Edens N.K., Kral J.G. Lipolysis in intraabdominal adipose tissues of obese women and men. Obes. Res. 1993, 1:443-448.
232. Rebuffe-Scrive M., Anderson B., Olbe L., Bjorntorp P. Metabolism of adipose tissue in intraabdominal depots in severely obese men and women. Metabolism 1990, 39:1021-1025.
233. Tchernof A., Belanger C., Morisset A.S., Richard C., Mailloux J., Laberge P., Dupont P. Regional differences in adipose tissue metabolism in women: minor effect of obesity and body fat distribution. Diabetes 2006, 55:1353-1360.
234. Boivin A., Brochu G., Marceau S., Marceau P., Hould F.S., Tchernof A. Regional differences in adipose tissue metabolism in obese men. Metabolism 2007, 56:533-540.
235. Horowitz J.F., Klein S. Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women. Am. J. Physiol. Endocrinol. Metab. 2000, 278:E1144-E1152.
236. Guo Z., Johnson C.M., Jensen M.D. Regional lipolytic responses to isoproterenol in women. Am. J. Physiol. 1997, 273:E108-E112.
237. Jensen M.D., Cryer P.E., Johnson C.M., Murray M.J. Effects of epinephrine on regional free fatty acid and energy metabolism in men and women. Am. J. Physiol. 1996, 270:E259-E264.
238. Arner P., Kriegholm E., Engfeldt P., Bolinder J. Adrenergic regulation of lipolysis in situ at rest and during exercise. J. Clin. Invest. 1990, 85:893-898.
239. Gjedsted J., Gormsen L.C., Nielsen S., Schmitz O., Djurhuus C.B., Keiding S., Orskov H., Tonnesen E., Moller N. Effects of a 3-day fast on regional lipid and glucose metabolism in human skeletal muscle and adipose tissue. Acta Physiol (Oxf.) 2007, 191:205-216.
240. Martin M.L., Jensen M.D. Effects of body fat distribution on regional lipolysis in obesity. J. Clin. Invest. 1991, 88:609-613.
241. Gavin K.M., Cooper E.E., Raymer D.K., Hickner R.C. Estradiol effects on subcutaneous adipose tissue lipolysis in premenopausal women are adipose tissue depot specific and treatment dependent, American Journal of Physiology. Endocrinol. Metab. 2013.
242. Pedersen S.B., Kristensen K., Hermann P.A., Katzenellenbogen J.A., Richelsen B. Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J. Clin. Endocrinol. Metab. 2004, 89:1869-1878.
243. Dicker A., Ryden M., Naslund E., Muehlen I.E., Wiren M., Lafontan M., Arner P. Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots. Diabetologia 2004, 47:420-428.
244. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann. Med. 1995, 27:435-438.
245. Tan G.D., Goossens G.H., Humphreys S.M., Vidal H., Karpe F. Upper and lower body adipose tissue function: a direct comparison of fat mobilization in humans. Obes. Res. 2004, 12:114-118.
246. Jensen M.D., Haymond M.W., Rizza R.A., Cryer P.E., Miles J.M. Influence of body fat distribution on free fatty acid metabolism in obesity. J. Clin. Invest. 1989, 83:1168-1173.
247. Jensen M.D. Gender differences in regional fatty acid metabolism before and after meal ingestion. J. Clin. Invest. 1995, 96:2297-2303.
248. Dowling H.J., Fried S.K., Pi-Sunyer F.X. Insulin resistance in adipocytes of obese women: effects of body fat distribution and race. Metabolism 1995, 44:987-995.
249. Meek S.E., Nair K.S., Jensen M.D. Insulin regulation of regional free fatty acid metabolism. Diabetes 1999, 48:10-14.
250. Roust L.R., Jensen M.D. Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes 1993, 42:1567-1573.
251. Leibel R.L., Edens N.K., Fried S.K. Physiologic basis for the control of body fat distribution in humans. Annu. Rev. Nutr. 1989, 9:417-443.
252. Arner P., Hellstrom L., Wahrenberg H., Bronnegard M. Beta-adrenoceptor expression in human fat cells from different regions. J. Clin. Invest. 1990, 86:1595-1600.
253. Lonnqvist F., Thorne A., Large V., Arner P. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler. Thromb. Vasc. Biol. 1997, 17:1472-1480.
254. Soeters M.R., Sauerwein H.P., Groener J.E., Aerts J.M., Ackermans M.T., Glatz J.F., Fliers E., Serlie M.J. Gender-related differences in the metabolic response to fasting. J. Clin. Endocrinol. Metab. 2007, 92:3646-3652.
255. Horowitz J.F., Coppack S.W., Paramore D., Cryer P.E., Zhao G., Klein S. Effect of short-term fasting on lipid kinetics in lean and obese women. Am. J. Physiol. 1999, 276:E278-E284.
256. Nielsen S., Guo Z., Johnson C.M., Hensrud D.D., Jensen M.D. Splanchnic lipolysis in human obesity. J. Clin. Invest. 2004, 113:1582-1588.
257. Boden G., Chen X. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J. Clin. Invest. 1995, 96:1261-1268.
258. Roden M., Price T.B., Perseghin G., Petersen K.F., Rothman D.L., Cline G.W., Shulman G.I. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 1996, 97:2859-2865.
259. Saloranta C., Franssila-Kallunki A., Ekstrand A., Taskinen M.R., Groop L. Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1991, 34:409-415.
260. Rebrin K., Steil G.M., Getty L., Bergman R.N. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 1995, 44:1038-1045.
261. Havel R.J., Kane J.P., Balasse E.O., Segel N., Basso L.V. Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J. Clin. Invest. 1970, 49:2017-2035.
262. Kissebah A.H., Adams P.W., Wynn V. Plasma free fatty acid and triglyceride transport kinetics in man. Clin. Sci. Mol. Med. 1974, 47:259-278.
263. Kissebah A.H., Alfarsi S., Adams P.W., Wynn V. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 1976, 12:563-571.
264. Arner P., Lithell H., Wahrenberg H., Bronnegard M. Expression of lipoprotein lipase in different human subcutaneous adipose tissue regions. J. Lipid Res. 1991, 32:423-429.
265. Pouliot M.C., Despres J.P., Moorjani S., Lupien P.J., Tremblay A., Nadeau A., Bouchard C. Regional variation in adipose tissue lipoprotein lipase activity: association with plasma high density lipoprotein levels. Eur. J. Clin. Invest. 1991, 21:398-405.
266. Fried S.K., Kral J.G. Sex differences in regional distribution of fat cell size and lipoprotein lipase activity in morbidly obese patients. Int. J. Obes. 1987, 11:129-140.
267. Ramirez M.E., McMurry M.P., Wiebke G.A., Felten K.J., Ren K., Meikle A.W., Iverius P.H. Evidence for sex steroid inhibition of lipoprotein lipase in men: comparison of abdominal and femoral adipose tissue. Metabolism 1997, 46:179-185.
268. Marin P., Oden B., Bjorntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J. Clin. Endocrinol. Metab. 1995, 80:239-243.
269. Price T.M., O'Brien S.N., Welter B.H., George R., Anandjiwala J., Kilgore M. Estrogen regulation of adipose tissue lipoprotein lipase-possible mechanism of body fat distribution. Am. J. Obstet. Gynecol. 1998, 178:101-107.
270. Blouin K., Nadeau M., Perreault M., Veilleux A., Drolet R., Marceau P., Mailloux J., Luu-The V., Tchernof A. Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women. Clin. Endocrinol. 2010, 72:176-188.
271. Doolittle M.H., Ben-Zeev O., Elovson J., Martin D., Kirchgessner T.G. The response of lipoprotein lipase to feeding and fasting. Evidence for posttranslational regulation, J Biol Chem 1990, 265:4570-4577.
272. Romanski S.A., Nelson R.M., Jensen M.D. Meal fatty acid uptake in adipose tissue: gender effects in nonobese humans. Am. J. Physiol. Endocrinol. Metab. 2000, 279:E455-E462.
273. Koutsari C., Snozek C.L., Jensen M.D. Plasma NEFA storage in adipose tissue in the postprandial state: sex-related and regional differences. Diabetologia 2008, 51:2041-2048.
274. Votruba S.B., Jensen M.D. Sex-specific differences in leg fat uptake are revealed with a high-fat meal. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E1115-E1123.
275. Santosa S., Hensrud D.D., Votruba S.B., Jensen M.D. The influence of sex and obesity phenotype on meal fatty acid metabolism before and after weight loss. Am. J. Clin. Nutr. 2008, 88:1134-1141.
276. Nguyen T.T., Hernandez Mijares A., Johnson C.M., Jensen M.D. Postprandial leg and splanchnic fatty acid metabolism in nonobese men and women. Am. J. Physiol. 1996, 271:E965-E972.
277. Jensen M.D., Sarr M.G., Dumesic D.A., Southorn P.A., Levine J.A. Regional uptake of meal fatty acids in humans. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E1282-E1288.
278. Shadid S., Koutsari C., Jensen M.D. Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution. Diabetes 2007, 56:1369-1375.
279. Koutsari C., Ali A.H., Mundi M.S., Jensen M.D. Storage of circulating free fatty acid in adipose tissue of postabsorptive humans: quantitative measures and implications for body fat distribution. Diabetes 2011, 60:2032-2040.
280. Koutsari C., Mundi M.S., Ali A.H., Jensen M.D. Storage rates of circulating free fatty acid into adipose tissue during eating or walking in humans. Diabetes 2012, 61:329-338.
281. Frayn K.N. Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002, 45:1201-1210.
282. Hernandez T.L., Kittelson J.M., Law C.K., Ketch L.L., Stob N.R., Lindstrom R.C., Scherzinger A., Stamm E.R., Eckel R.H. Fat redistribution following suction lipectomy: defense of body fat and patterns of restoration. Obesity (Silver Spring) 2011, 19:1388-1395.